Donald Berry
Physician Assistant · Troy, MINPI 1164870275
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,662 of the $18,437 with a category attached, or 74.1%. It is spread thinly across 54 manufacturers, the largest accounting for just 21.0%. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 615 payments — averaging $29.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$4K
- Axonics, Inc.$2K
- Coloplast$1K
- Sumitomo Pharma America, Inc.$1K
- Astellas Pharma US Inc$1K
- Johnson & Johnson$867
- plus $8K from 48 others
What the payments were for
- Travel & lodging$4,20323%
- Food & beverage$13,66274%
- Education$5733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,437 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 248 | $190,346 |
| GemtesaVibegron | 144 | $127,277 |
| Mirabegron ErMirabegron | 57 | $47,756 |
| Tolterodine Tartrate ErTolterodine Tartrate | 67 | $5,526 |
| Tamsulosin Hcl | 177 | $3,454 |
| Potassium Citrate ErPotassium Citrate | 13 | $2,887 |
| Methenamine Hippurate | 40 | $2,603 |
| Finasteride | 71 | $1,250 |
| Oxybutynin Chloride ErOxybutynin Chloride | 51 | $1,239 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 74 | $1,088 |
| Cephalexin | 87 | $729 |
| Solifenacin Succinate | 18 | $537 |
| Testosterone Cypionate | 12 | $531 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $403 |
| Cefdinir | 27 | $299 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $1,092 | $190,346248 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $1,153 | $127,277144 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Troy
- Michael LutherTroy$14K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.